Exposure–Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting
René J. Boosman, M. Jebbink, Wouter B. Veldhuis, Stefanie L. Groenland, Bianca van Veggel, Pim Moeskops, Adrianus J. de Langen, Jos H. Beijnen, Egbert F. Smit, Alwin D. R. Huitema, Neeltje Steeghs
Topics & Concepts
OsimertinibCminLung cancerMedicineInternal medicineHazard ratioOncologyConfidence intervalPharmacokineticsEpidermal growth factor receptorPharmacodynamicsToxicityPharmacologyGastroenterologyCancerCmaxErlotinibLung Cancer Treatments and MutationsChronic Myeloid Leukemia TreatmentsLung Cancer Research Studies